Palvella appoints Matthew Pauls to its board as Class I director

Palvella appointed Matthew Pauls to its Board as a Class I director, effective June 29, 2026.Original SEC Filing: PALVELLA THERAPEUTICS, INC. [ PVLA ] - 8-K - Jun. 30, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please no…

Palvella appointed Matthew Pauls to its Board as a Class I director, effective June 29, 2026.

IndividualMatthew Pauls

RoleClass I director

Type of ChangeAppointed

Effective DateJune 29, 2026

ReasonBoard increased size from seven to eight members and appointed Mr. Pauls upon committee recommendation

Replacement InfoNot disclosed

Background DetailsCEO of Savara since Dec 2020; prior CEO of Strongbridge; former CCO of Insmed; board roles at Savara, Pelthos, Atsena; J.D., B.S., MBA

Board/Committee Role ChangesNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.